首页 > 最新文献

Clinical and Translational Medicine最新文献

英文 中文
Transcriptome profiles of human preimplantation blastocysts related to mosaicism, developmental speed and competence
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-24 DOI: 10.1002/ctm2.70196
Song Li, Bing Cai, Jialiu Liu, Yan Xu, Chenhui Ding, Muhua Lai, Canquan Zhou, Yanwen Xu
<p>Dear Editor,</p><p>By taking advantage of parallel sequencing of genome and transcriptome (G&T-seq),<span><sup>1</sup></span> we demonstrated the distinct transcriptome profiles of human preimplantation blastocysts in perspectives of embryo digital karyotype, developmental speed and implantation competence. Our study provided valuable information for further research in the physiology behind human embryo development and laid the foundation for embryo selection from the view of the transcriptome.</p><p>Preimplantation genetic test for aneuploidy (PGT-A) serves as an important invasive method to select euploid embryos. However, even PGT-A cannot guarantee a successful pregnancy,<span><sup>2</sup></span> for almost 50% of euploid blastocysts could not result in a live birth. It means that there is still a big room to improve the capability of embryo selection besides aneuploidy screening. RNA sequencing might have the potential for assessing embryo competence.<span><sup>3, 4</sup></span> Here we investigated the distinct transcriptome profiles in human pre-implantation blastocysts with the application of G&T-seq (Figure 1A). We have verified this method in biopsied samples from 41 donated blastocysts in terms of the transcriptome consistency of samples from the same blastocyst, the prediction value of aneuploidies by transcriptome (Figure S1), as well as the lineage characteristic of inner cell mass (ICM) and trophectoderm (TE) (Figure S2), indicating the clinical safety and reproducibility of this method.</p><p>G&T-seq is a unique technology for studying the transcriptome of chromosomal mosaicism, taking advantage of separate genome sequencing and RNA sequencing. In comparisons of transcriptomes of 28 TE few-cell samples from eight mosaic embryos with 17 TE few-cell samples from five euploidies (Figure 1B), we identified 79 genes upregulated and 37 genes downregulated (Figure 1C). Notably, ectoderm and primitive endoderm genes, including <i>KLF4</i>, <i>TGFBR1</i>, <i>ITGB5</i> and <i>GATA6</i>, were significantly upregulated in TE of mosaic blastocysts (Figure 1D). Furthermore, upregulated genes were mainly enriched in embryonic development, stem cell proliferation, endoderm development and other pathways (Table S1), implying that there might be a lineage separation disorder in TE cells with chromosomal mosaicism, and the inadequately developed trophoblast may contribute to the adverse pregnancy outcomes of mosaic embryos.</p><p>Human blastocysts have different developmental speeds. It may take 5–7 days for an embryo to develop to the grade 4 stage according to the Gardner grading system, which is the stage allowing TE biopsy. Clinically, blastocysts biopsied on day 6 or day 7 (named D6 or D7 blastocyst) are defined as growth-retarded blastocysts with lower implantation potential compared with day 5 blastocysts. The reason for retarded development speed remains to be clarified. To investigate the transcriptome related to blastocyst
{"title":"Transcriptome profiles of human preimplantation blastocysts related to mosaicism, developmental speed and competence","authors":"Song Li,&nbsp;Bing Cai,&nbsp;Jialiu Liu,&nbsp;Yan Xu,&nbsp;Chenhui Ding,&nbsp;Muhua Lai,&nbsp;Canquan Zhou,&nbsp;Yanwen Xu","doi":"10.1002/ctm2.70196","DOIUrl":"10.1002/ctm2.70196","url":null,"abstract":"&lt;p&gt;Dear Editor,&lt;/p&gt;&lt;p&gt;By taking advantage of parallel sequencing of genome and transcriptome (G&amp;T-seq),&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; we demonstrated the distinct transcriptome profiles of human preimplantation blastocysts in perspectives of embryo digital karyotype, developmental speed and implantation competence. Our study provided valuable information for further research in the physiology behind human embryo development and laid the foundation for embryo selection from the view of the transcriptome.&lt;/p&gt;&lt;p&gt;Preimplantation genetic test for aneuploidy (PGT-A) serves as an important invasive method to select euploid embryos. However, even PGT-A cannot guarantee a successful pregnancy,&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; for almost 50% of euploid blastocysts could not result in a live birth. It means that there is still a big room to improve the capability of embryo selection besides aneuploidy screening. RNA sequencing might have the potential for assessing embryo competence.&lt;span&gt;&lt;sup&gt;3, 4&lt;/sup&gt;&lt;/span&gt; Here we investigated the distinct transcriptome profiles in human pre-implantation blastocysts with the application of G&amp;T-seq (Figure 1A). We have verified this method in biopsied samples from 41 donated blastocysts in terms of the transcriptome consistency of samples from the same blastocyst, the prediction value of aneuploidies by transcriptome (Figure S1), as well as the lineage characteristic of inner cell mass (ICM) and trophectoderm (TE) (Figure S2), indicating the clinical safety and reproducibility of this method.&lt;/p&gt;&lt;p&gt;G&amp;T-seq is a unique technology for studying the transcriptome of chromosomal mosaicism, taking advantage of separate genome sequencing and RNA sequencing. In comparisons of transcriptomes of 28 TE few-cell samples from eight mosaic embryos with 17 TE few-cell samples from five euploidies (Figure 1B), we identified 79 genes upregulated and 37 genes downregulated (Figure 1C). Notably, ectoderm and primitive endoderm genes, including &lt;i&gt;KLF4&lt;/i&gt;, &lt;i&gt;TGFBR1&lt;/i&gt;, &lt;i&gt;ITGB5&lt;/i&gt; and &lt;i&gt;GATA6&lt;/i&gt;, were significantly upregulated in TE of mosaic blastocysts (Figure 1D). Furthermore, upregulated genes were mainly enriched in embryonic development, stem cell proliferation, endoderm development and other pathways (Table S1), implying that there might be a lineage separation disorder in TE cells with chromosomal mosaicism, and the inadequately developed trophoblast may contribute to the adverse pregnancy outcomes of mosaic embryos.&lt;/p&gt;&lt;p&gt;Human blastocysts have different developmental speeds. It may take 5–7 days for an embryo to develop to the grade 4 stage according to the Gardner grading system, which is the stage allowing TE biopsy. Clinically, blastocysts biopsied on day 6 or day 7 (named D6 or D7 blastocyst) are defined as growth-retarded blastocysts with lower implantation potential compared with day 5 blastocysts. The reason for retarded development speed remains to be clarified. To investigate the transcriptome related to blastocyst ","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 2","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11761386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatial distribution of immune cells and their proximity to STING+ cells are associated with survival in glioblastoma
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-24 DOI: 10.1002/ctm2.70187
Hanwool Jeon, Hayeong Kang, Jihyun Im, Suin Jo, Hyunchul Jung, Moinay Kim, Jae Hyun Kim, Eunyeup Lee, Soyoung Kim, Jeong Hoon Kim, Chang-Ki Hong, Young-Hoon Kim, Sang Woo Song, Jinha Park, Sang-Yeob Kim, Seungjoo Lee
<p>Dear Editor,</p><p>Glioblastoma (GBM), the most aggressive malignant tumour, is increasingly treated with immunotherapy.<span><sup>1-3</sup></span> The stimulator of interferon genes (STING) pathway<span><sup>4</sup></span> is key to tumour immunity and a studied target for immunotherapy.<span><sup>5</sup></span> This study explores the immune landscape of GBM, focusing on spatial relationships between tumour-associated immune cells (TAICs)<span><sup>6</sup></span> and STING-expressing cells, uncovering patterns linked to prognosis.</p><p>We studied 14 recurrent GBM patients using protein composition and Gene Ontology (GO) analysis and analyzed immune pathways in 69 newly diagnosed GBM patients undergoing standard therapy. Spatial analysis of cells was performed using QuPath, CytoMAP, and R, as illustrated in Figure 1A. From our proteomic analysis, we identified protein groups with marked upregulation in patients with favourable responses. A total of 99 proteins were highly upregulated in the favourable group, while 170 were more pronounced in the unfavourable group (Figure 1B). Clusters of downregulated and upregulated proteins were identified using the Benjamini-Hochberg False Discovery Rate. The expression of <b>TMEM173</b>, the gene encoding STING, was significantly elevated in the favourable group, as measured by protein expression using a mass spectrometer. The results were represented as an abundance ratio, and statistical significance was confirmed using the adjusted p-value. (Figure 1C). GO analysis showed that upregulated proteins in the favourable group were mainly linked to immune response activation. (Figure 1D). Pathways such as ‘regulation of innate immune response’ and ‘phagocytic respiratory burst’ were strongly linked to innate immune activation (Figure 1E). Additionally, pathways like ‘cell surface receptor signalling in immune response’, ‘T cell migration’ and ‘positive regulation of T cell receptor signalling’ were significantly linked to immune response activation (Figure 1F). <i>p</i>-Values were transformed to -log10 for statistical significance, with values above 1.3 considered significant. Table S1 provides the GO categories associated with immune response activation.</p><p>We used multiplex immunohistochemistry (IHC) to analyze immune cell distribution and protein markers in the TME. Markers included CD4<sup>+</sup> (helper T cells), CD8<sup>+</sup> (cytotoxic T cells), CD11c<sup>+</sup> (dendritic cells), TCRγ/δ<sup>+</sup> (γ/δ T cells), ATRX<sup>+</sup> (tumour cells) and DAPI<sup>+</sup> (nuclei), with STING as a primary marker of interest.</p><p>We explored correlations between immune cell populations identified by multiplex IHC and patient survival (Figure 2A). Tumour specimens were stained with multiplex immunofluorescence, and a pathologist selected regions of interest (ROIs), which were scanned at high magnification and analyzed with markers including ATRX, CD8, STING, DAPI, CD4, CD11c and TCRγ/δ. (Figure 2B
{"title":"Spatial distribution of immune cells and their proximity to STING+ cells are associated with survival in glioblastoma","authors":"Hanwool Jeon,&nbsp;Hayeong Kang,&nbsp;Jihyun Im,&nbsp;Suin Jo,&nbsp;Hyunchul Jung,&nbsp;Moinay Kim,&nbsp;Jae Hyun Kim,&nbsp;Eunyeup Lee,&nbsp;Soyoung Kim,&nbsp;Jeong Hoon Kim,&nbsp;Chang-Ki Hong,&nbsp;Young-Hoon Kim,&nbsp;Sang Woo Song,&nbsp;Jinha Park,&nbsp;Sang-Yeob Kim,&nbsp;Seungjoo Lee","doi":"10.1002/ctm2.70187","DOIUrl":"10.1002/ctm2.70187","url":null,"abstract":"&lt;p&gt;Dear Editor,&lt;/p&gt;&lt;p&gt;Glioblastoma (GBM), the most aggressive malignant tumour, is increasingly treated with immunotherapy.&lt;span&gt;&lt;sup&gt;1-3&lt;/sup&gt;&lt;/span&gt; The stimulator of interferon genes (STING) pathway&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt; is key to tumour immunity and a studied target for immunotherapy.&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; This study explores the immune landscape of GBM, focusing on spatial relationships between tumour-associated immune cells (TAICs)&lt;span&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt; and STING-expressing cells, uncovering patterns linked to prognosis.&lt;/p&gt;&lt;p&gt;We studied 14 recurrent GBM patients using protein composition and Gene Ontology (GO) analysis and analyzed immune pathways in 69 newly diagnosed GBM patients undergoing standard therapy. Spatial analysis of cells was performed using QuPath, CytoMAP, and R, as illustrated in Figure 1A. From our proteomic analysis, we identified protein groups with marked upregulation in patients with favourable responses. A total of 99 proteins were highly upregulated in the favourable group, while 170 were more pronounced in the unfavourable group (Figure 1B). Clusters of downregulated and upregulated proteins were identified using the Benjamini-Hochberg False Discovery Rate. The expression of &lt;b&gt;TMEM173&lt;/b&gt;, the gene encoding STING, was significantly elevated in the favourable group, as measured by protein expression using a mass spectrometer. The results were represented as an abundance ratio, and statistical significance was confirmed using the adjusted p-value. (Figure 1C). GO analysis showed that upregulated proteins in the favourable group were mainly linked to immune response activation. (Figure 1D). Pathways such as ‘regulation of innate immune response’ and ‘phagocytic respiratory burst’ were strongly linked to innate immune activation (Figure 1E). Additionally, pathways like ‘cell surface receptor signalling in immune response’, ‘T cell migration’ and ‘positive regulation of T cell receptor signalling’ were significantly linked to immune response activation (Figure 1F). &lt;i&gt;p&lt;/i&gt;-Values were transformed to -log10 for statistical significance, with values above 1.3 considered significant. Table S1 provides the GO categories associated with immune response activation.&lt;/p&gt;&lt;p&gt;We used multiplex immunohistochemistry (IHC) to analyze immune cell distribution and protein markers in the TME. Markers included CD4&lt;sup&gt;+&lt;/sup&gt; (helper T cells), CD8&lt;sup&gt;+&lt;/sup&gt; (cytotoxic T cells), CD11c&lt;sup&gt;+&lt;/sup&gt; (dendritic cells), TCRγ/δ&lt;sup&gt;+&lt;/sup&gt; (γ/δ T cells), ATRX&lt;sup&gt;+&lt;/sup&gt; (tumour cells) and DAPI&lt;sup&gt;+&lt;/sup&gt; (nuclei), with STING as a primary marker of interest.&lt;/p&gt;&lt;p&gt;We explored correlations between immune cell populations identified by multiplex IHC and patient survival (Figure 2A). Tumour specimens were stained with multiplex immunofluorescence, and a pathologist selected regions of interest (ROIs), which were scanned at high magnification and analyzed with markers including ATRX, CD8, STING, DAPI, CD4, CD11c and TCRγ/δ. (Figure 2B","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 2","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11761387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-24 DOI: 10.1002/ctm2.70078
Sally E. Claridge, Shalini Nath, Anneliese Baum, Richard Farias, Julie-Ann Cavallo, Nile M. Rizvi, Lamberto De Boni, Eric Park, Genesis Lara Granados, Matthew Hauesgen, Ruben Fernandez-Rodriguez, Eda Nur Kozan, Evgeny Kanshin, Khoi Q. Huynh, Peng-Jen Chen, Kenneth Wu, Beatrix Ueberheide, Juan Miguel Mosquera, Fred R. Hirsch, Robert J. DeVita, Olivier Elemento, Chantal Pauli, Zhen-Qiang Pan, Benjamin D. Hopkins
<div> <section> <h3> Background</h3> <p>The goal of precision oncology is to find effective therapeutics for every patient. Through the inclusion of emerging therapeutics in a high-throughput drug screening platform, our functional genomics pipeline inverts the common paradigm to identify patient populations that are likely to benefit from novel therapeutic strategies.</p> </section> <section> <h3> Approach</h3> <p>Utilizing drug screening data across a panel of 46 cancer cell lines from 11 tumor lineages, we identified an ovarian cancer-specific sensitivity to the first-in-class CRL4 inhibitors KH-4-43 and 33-11. CRL4 (i.e., Cullin-4 RING E3 ubiquitin ligase) is known to be dysregulated in a variety of cancer contexts, making it an attractive therapeutic target. Unlike proteasome inhibitors that are associated with broad toxicity, CRL4 inhibition offers the potential for tumor-specific effects.</p> </section> <section> <h3> Results</h3> <p>We observed that CRL4 inhibition negatively regulates core gene signatures that are upregulated in ovarian tumors and significantly slowed tumor growth as compared to the standard of care, cisplatin, in OVCAR8 xenografts. Building on this, we performed combination drug screening in conjunction with proteomic and transcriptomic profiling to identify ways to improve the antitumor effects of CRL4 inhibition in ovarian cancer models. CRL4 inhibition consistently resulted in activation of the mitogen-activated protein kinase (MAPK) signaling cascade at both the transcriptomic and protein levels, suggesting that survival signaling is induced in response to CRL4 inhibition. These observations were concordant with the results of the combination drug screens in seven ovarian cancer cell lines that showed CRL4 inhibition cooperates with MEK inhibition. Preclinical studies in OVCAR8 and A2780 xenografts confirmed the therapeutic potential of the combination of KH-4-43 and trametinib, which extended overall survival and slowed tumor progression relative to either single agent or the standard of care.</p> </section> <section> <h3> Conclusions</h3> <p>Together, these data demonstrate the prospective utility of functional modeling pipelines for therapeutic development and underscore the clinical potential of CRL4 inhibition in the ovarian cancer context.</p> </section> <section> <h3> Highlights</h3> <div> <ul> <li> <p>A precision medicine pipe
{"title":"Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer","authors":"Sally E. Claridge,&nbsp;Shalini Nath,&nbsp;Anneliese Baum,&nbsp;Richard Farias,&nbsp;Julie-Ann Cavallo,&nbsp;Nile M. Rizvi,&nbsp;Lamberto De Boni,&nbsp;Eric Park,&nbsp;Genesis Lara Granados,&nbsp;Matthew Hauesgen,&nbsp;Ruben Fernandez-Rodriguez,&nbsp;Eda Nur Kozan,&nbsp;Evgeny Kanshin,&nbsp;Khoi Q. Huynh,&nbsp;Peng-Jen Chen,&nbsp;Kenneth Wu,&nbsp;Beatrix Ueberheide,&nbsp;Juan Miguel Mosquera,&nbsp;Fred R. Hirsch,&nbsp;Robert J. DeVita,&nbsp;Olivier Elemento,&nbsp;Chantal Pauli,&nbsp;Zhen-Qiang Pan,&nbsp;Benjamin D. Hopkins","doi":"10.1002/ctm2.70078","DOIUrl":"10.1002/ctm2.70078","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The goal of precision oncology is to find effective therapeutics for every patient. Through the inclusion of emerging therapeutics in a high-throughput drug screening platform, our functional genomics pipeline inverts the common paradigm to identify patient populations that are likely to benefit from novel therapeutic strategies.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Approach&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Utilizing drug screening data across a panel of 46 cancer cell lines from 11 tumor lineages, we identified an ovarian cancer-specific sensitivity to the first-in-class CRL4 inhibitors KH-4-43 and 33-11. CRL4 (i.e., Cullin-4 RING E3 ubiquitin ligase) is known to be dysregulated in a variety of cancer contexts, making it an attractive therapeutic target. Unlike proteasome inhibitors that are associated with broad toxicity, CRL4 inhibition offers the potential for tumor-specific effects.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We observed that CRL4 inhibition negatively regulates core gene signatures that are upregulated in ovarian tumors and significantly slowed tumor growth as compared to the standard of care, cisplatin, in OVCAR8 xenografts. Building on this, we performed combination drug screening in conjunction with proteomic and transcriptomic profiling to identify ways to improve the antitumor effects of CRL4 inhibition in ovarian cancer models. CRL4 inhibition consistently resulted in activation of the mitogen-activated protein kinase (MAPK) signaling cascade at both the transcriptomic and protein levels, suggesting that survival signaling is induced in response to CRL4 inhibition. These observations were concordant with the results of the combination drug screens in seven ovarian cancer cell lines that showed CRL4 inhibition cooperates with MEK inhibition. Preclinical studies in OVCAR8 and A2780 xenografts confirmed the therapeutic potential of the combination of KH-4-43 and trametinib, which extended overall survival and slowed tumor progression relative to either single agent or the standard of care.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Together, these data demonstrate the prospective utility of functional modeling pipelines for therapeutic development and underscore the clinical potential of CRL4 inhibition in the ovarian cancer context.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Highlights&lt;/h3&gt;\u0000 \u0000 &lt;div&gt;\u0000 &lt;ul&gt;\u0000 \u0000 &lt;li&gt;\u0000 &lt;p&gt;A precision medicine pipe","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 2","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11761363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin K-dependent gamma-carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-22 DOI: 10.1002/ctm2.70191
Zheng Wu, Qing Ye, Shan Zhang, Li-Peng Hu, Xiao-Qi Wang, Lin-Li Yao, Lei Zhu, Shu-Yu Xiao, Zong-Hao Duan, Xue-Li Zhang, Shu-Heng Jiang, Zhi-Gang Zhang, De-Jun Liu, Dong-Xue Li, Xiao-Mei Yang
<div> <section> <h3> Background</h3> <p>Vitamin K-dependent γ-glutamic acid carboxylation (Gla) proteins are calcium-binding and membrane-associated, participating in coagulation, bone turnover, and cancer biology. The molecular function of transmembrane proline-rich Gla proteins (PRRGs) remains unexplored.</p> </section> <section> <h3> Methods</h3> <p>Analysis of pancreatic ductal adenocarcinoma (PDAC) datasets, including transcription profiles, clinical data, and tissue microarrays, was conducted to evaluate PRRG1 expression and its clinical relevance. PDAC cell lines with overexpressed, knockdown, and mutated PRRG1 were developed to study biological functions and pathways using RNA-seq, co-immunoprecipitation with mass spectrometry, Western blotting, and immunofluorescence. In vivo xenograft and orthotopic models assessed PRRG1's impact on PDAC progression, with and without warfarin treatment.</p> </section> <section> <h3> Results</h3> <p>PRRG1 was significantly upregulated in PDAC compared to normal pancreas, correlating with poorer patient survival. PRRG1 knockdown reduced PDAC cell proliferation, anchorage-independent growth in vitro, and tumor growth in vivo. PRRG1 localized at the plasma membrane, interacted with the HECT E3 ligase NEDD4 via the C-terminal PPXY motif, and promoted NEDD4 self-ubiquitination, reducing its protein levels. PRRG1 knockdown elevated NEDD4, destabilizing the oncoprotein KRAS and receptor EGFR, and attenuating downstream signaling and macropinocytosis under nutrient deprivation. The vitamin K-dependent Gla modification of PRRG1 was crucial for its membrane localization and pro-tumorigenic effects, and was inhibited by low-dose warfarin, a clinical vitamin K antagonist.</p> </section> <section> <h3> Conclusions</h3> <p>This study identifies PRRG1 as a key regulator of pro-tumorigenic signaling in PDAC, suggesting the potential of repurposing the anticoagulant warfarin as a therapeutic strategy.</p> </section> <section> <h3> Key points</h3> <div> <ul> <li>PRRG1 is identified as the transmembrane Gla protein mediating PDAC malignancy.</li> <li>PRRG1 recruits and induces self-ubiquitination of membrane-anchoring E3 ligase NEDD4.</li> <li>PRRG1 exerts a protective role toward KRAS and EGFR by inhibiting NEDD4.</li> <li>The anticoagul
{"title":"Vitamin K-dependent gamma-carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR","authors":"Zheng Wu,&nbsp;Qing Ye,&nbsp;Shan Zhang,&nbsp;Li-Peng Hu,&nbsp;Xiao-Qi Wang,&nbsp;Lin-Li Yao,&nbsp;Lei Zhu,&nbsp;Shu-Yu Xiao,&nbsp;Zong-Hao Duan,&nbsp;Xue-Li Zhang,&nbsp;Shu-Heng Jiang,&nbsp;Zhi-Gang Zhang,&nbsp;De-Jun Liu,&nbsp;Dong-Xue Li,&nbsp;Xiao-Mei Yang","doi":"10.1002/ctm2.70191","DOIUrl":"10.1002/ctm2.70191","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Vitamin K-dependent γ-glutamic acid carboxylation (Gla) proteins are calcium-binding and membrane-associated, participating in coagulation, bone turnover, and cancer biology. The molecular function of transmembrane proline-rich Gla proteins (PRRGs) remains unexplored.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Analysis of pancreatic ductal adenocarcinoma (PDAC) datasets, including transcription profiles, clinical data, and tissue microarrays, was conducted to evaluate PRRG1 expression and its clinical relevance. PDAC cell lines with overexpressed, knockdown, and mutated PRRG1 were developed to study biological functions and pathways using RNA-seq, co-immunoprecipitation with mass spectrometry, Western blotting, and immunofluorescence. In vivo xenograft and orthotopic models assessed PRRG1's impact on PDAC progression, with and without warfarin treatment.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;PRRG1 was significantly upregulated in PDAC compared to normal pancreas, correlating with poorer patient survival. PRRG1 knockdown reduced PDAC cell proliferation, anchorage-independent growth in vitro, and tumor growth in vivo. PRRG1 localized at the plasma membrane, interacted with the HECT E3 ligase NEDD4 via the C-terminal PPXY motif, and promoted NEDD4 self-ubiquitination, reducing its protein levels. PRRG1 knockdown elevated NEDD4, destabilizing the oncoprotein KRAS and receptor EGFR, and attenuating downstream signaling and macropinocytosis under nutrient deprivation. The vitamin K-dependent Gla modification of PRRG1 was crucial for its membrane localization and pro-tumorigenic effects, and was inhibited by low-dose warfarin, a clinical vitamin K antagonist.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This study identifies PRRG1 as a key regulator of pro-tumorigenic signaling in PDAC, suggesting the potential of repurposing the anticoagulant warfarin as a therapeutic strategy.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Key points&lt;/h3&gt;\u0000 \u0000 &lt;div&gt;\u0000 &lt;ul&gt;\u0000 \u0000 &lt;li&gt;PRRG1 is identified as the transmembrane Gla protein mediating PDAC malignancy.&lt;/li&gt;\u0000 \u0000 &lt;li&gt;PRRG1 recruits and induces self-ubiquitination of membrane-anchoring E3 ligase NEDD4.&lt;/li&gt;\u0000 \u0000 &lt;li&gt;PRRG1 exerts a protective role toward KRAS and EGFR by inhibiting NEDD4.&lt;/li&gt;\u0000 \u0000 &lt;li&gt;The anticoagul","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 1","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143022302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Annexin A8 deficiency delays atherosclerosis progression 膜联蛋白A8缺乏可延缓动脉粥样硬化进展。
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-21 DOI: 10.1002/ctm2.70176
Carmen Gutiérrez-Muñoz, Rafael Blázquez-Serra, Irene San Sebastian-Jaraba, Sandra Sanz-Andrea, Maria J. Fernández-Gómez, Gonzalo Nuñez-Moreno, Pablo Mínguez, Joan Carles Escolá-Gil, Paula Nogales, Veronique Ollivier, Jose L. Martín-Ventura, Benoit Ho-Tin Noe, Ursula Rescher, Nerea Méndez-Barbero, Luis M. Blanco-Colio
<div> <section> <h3> Background</h3> <p>Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipids and leukocytes within the arterial wall. By studying the aortic transcriptome of atherosclerosis-prone apolipoprotein E (<i>ApoE<sup>−/−</sup>)</i> mice, we aimed to identify novel players in the progression of atherosclerosis.</p> </section> <section> <h3> Methods</h3> <p>RNA-Seq analysis was performed on aortas from <i>ApoE<sup>−/−</sup></i> and wild-type mice. AnxA8 expression was assessed in human and mice atherosclerotic tissue and healthy aorta. <i>ApoE<sup>−/−</sup></i> mice lacking systemic AnxA8 (<i>ApoE<sup>−/−</sup>AnxA8<sup>−/−</sup></i>) were generated to assess the effect of AnxA8 deficiency on atherosclerosis. Bone marrow transplantation (BMT) was also performed to generate <i>ApoE<sup>−/−</sup></i> lacking AnxA8 specifically in bone marrow-derived cells. Endothelial-specific AnxA8 silencing in vivo was performed in <i>ApoE<sup>−/−</sup></i> mice. The functional role of AnxA8 was analysed in cultured murine cells.</p> </section> <section> <h3> Results</h3> <p>RNA-Seq unveiled <i>AnxA8</i> as one of the most significantly upregulated genes in atherosclerotic aortas of <i>ApoE<sup>−/−</sup></i> compared to wild-type mice. Moreover, AnxA8 was upregulated in human atherosclerotic plaques. Germline deletion of AnxA8 decreased the atherosclerotic burden, the size and volume of atherosclerotic plaques in the aortic root. Plaques of <i>ApoE<sup>−/−</sup>AnxA8<sup>−/−</sup></i> were characterized by lower lipid and inflammatory content, smaller necrotic core, thicker fibrous cap and less apoptosis compared with those in <i>ApoE<sup>−/−</sup>AnxA8<sup>+/+</sup></i>. BMT showed that hematopoietic AnxA8 deficiency had no effect on atherosclerotic progression. Oxidized low-density lipoprotein (ox-LDL) increased AnxA8 expression in murine aortic endothelial cells (MAECs). In vitro experiments revealed that <i>AnxA8</i> deficiency in MAECs suppressed P/E-selectin and CD31 expression and secretion induced by ox-LDL with a concomitant reduction in platelet and leukocyte adhesion. Intravital microscopy confirmed the reduction in leukocyte and platelet adhesion in <i>ApoE<sup>−/−</sup>AnxA8<sup>−/−</sup></i> mice. Finally, endothelial-specific silencing of AnxA8 decreased atherosclerosis progression.</p> </section> <section> <h3> Conclusion</h3> <p>Our findings demonstrate that AnxA8 promotes the progression of atherosclerosis by modulating endothelial−leukocyte interactions. Interventions capable of reducing AnxA8 expre
背景:动脉粥样硬化是一种以动脉壁内脂质和白细胞积聚为特征的慢性炎症性疾病。通过研究动脉粥样硬化易感性载脂蛋白E (ApoE-/-)小鼠的主动脉转录组,我们旨在确定动脉粥样硬化进展中的新参与者。方法:对ApoE-/-和野生型小鼠的主动脉进行RNA-Seq分析。在人和小鼠动脉粥样硬化组织和健康主动脉中检测AnxA8的表达。产生ApoE-/-系统性缺乏AnxA8的小鼠(ApoE-/-AnxA8-/-),以评估AnxA8缺乏对动脉粥样硬化的影响。骨髓移植(BMT)也可以在骨髓源性细胞中产生特异性缺乏ApoE-/-的AnxA8。在ApoE-/-小鼠体内进行内皮特异性AnxA8沉默。在小鼠培养细胞中分析了AnxA8的功能作用。结果:RNA-Seq显示,与野生型小鼠相比,ApoE-/-小鼠动脉粥样硬化主动脉中,AnxA8是表达上调最显著的基因之一。此外,AnxA8在人类动脉粥样硬化斑块中表达上调。种系缺失AnxA8可降低动脉粥样硬化负荷、主动脉根部动脉粥样硬化斑块的大小和体积。与ApoE-/- anxa8 +/+相比,ApoE-/- anxa8 -/-斑块的特点是脂质和炎症含量较低,坏死核心较小,纤维帽较厚,细胞凋亡较少。BMT显示造血AnxA8缺乏对动脉粥样硬化的进展没有影响。氧化低密度脂蛋白(ox-LDL)增加小鼠主动脉内皮细胞(MAECs)中AnxA8的表达。体外实验表明,MAECs中AnxA8缺乏可抑制ox-LDL诱导的P/ e -选择素和CD31的表达和分泌,同时血小板和白细胞粘附减少。活体显微镜证实ApoE-/- anxa8 -/-小鼠白细胞和血小板粘附减少。最后,内皮特异性沉默AnxA8可减少动脉粥样硬化的进展。结论:我们的研究结果表明,AnxA8通过调节内皮-白细胞相互作用促进动脉粥样硬化的进展。能够降低内皮细胞中AnxA8表达的干预措施可能会延缓动脉粥样硬化斑块的进展。本研究表明,AnxA8在动脉粥样硬化小鼠主动脉和人类动脉粥样硬化斑块中表达上调。种系AnxA8缺乏可减少小鼠血小板和白细胞向活化内皮的募集,以及动脉粥样硬化负荷、斑块大小和巨噬细胞积聚。AnxA8调控氧化低密度脂蛋白诱导的主动脉内皮细胞粘附分子的表达。我们的数据强烈表明,AnxA8通过调节免疫细胞对内膜的粘附和内流来促进疾病进展。内皮特异性沉默AnxA8可减少动脉粥样硬化进展。降低AnxA8表达的治疗干预可能会延缓动脉粥样硬化的进展。
{"title":"Annexin A8 deficiency delays atherosclerosis progression","authors":"Carmen Gutiérrez-Muñoz,&nbsp;Rafael Blázquez-Serra,&nbsp;Irene San Sebastian-Jaraba,&nbsp;Sandra Sanz-Andrea,&nbsp;Maria J. Fernández-Gómez,&nbsp;Gonzalo Nuñez-Moreno,&nbsp;Pablo Mínguez,&nbsp;Joan Carles Escolá-Gil,&nbsp;Paula Nogales,&nbsp;Veronique Ollivier,&nbsp;Jose L. Martín-Ventura,&nbsp;Benoit Ho-Tin Noe,&nbsp;Ursula Rescher,&nbsp;Nerea Méndez-Barbero,&nbsp;Luis M. Blanco-Colio","doi":"10.1002/ctm2.70176","DOIUrl":"10.1002/ctm2.70176","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipids and leukocytes within the arterial wall. By studying the aortic transcriptome of atherosclerosis-prone apolipoprotein E (&lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;)&lt;/i&gt; mice, we aimed to identify novel players in the progression of atherosclerosis.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;RNA-Seq analysis was performed on aortas from &lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;&lt;/i&gt; and wild-type mice. AnxA8 expression was assessed in human and mice atherosclerotic tissue and healthy aorta. &lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;&lt;/i&gt; mice lacking systemic AnxA8 (&lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;AnxA8&lt;sup&gt;−/−&lt;/sup&gt;&lt;/i&gt;) were generated to assess the effect of AnxA8 deficiency on atherosclerosis. Bone marrow transplantation (BMT) was also performed to generate &lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;&lt;/i&gt; lacking AnxA8 specifically in bone marrow-derived cells. Endothelial-specific AnxA8 silencing in vivo was performed in &lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;&lt;/i&gt; mice. The functional role of AnxA8 was analysed in cultured murine cells.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;RNA-Seq unveiled &lt;i&gt;AnxA8&lt;/i&gt; as one of the most significantly upregulated genes in atherosclerotic aortas of &lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;&lt;/i&gt; compared to wild-type mice. Moreover, AnxA8 was upregulated in human atherosclerotic plaques. Germline deletion of AnxA8 decreased the atherosclerotic burden, the size and volume of atherosclerotic plaques in the aortic root. Plaques of &lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;AnxA8&lt;sup&gt;−/−&lt;/sup&gt;&lt;/i&gt; were characterized by lower lipid and inflammatory content, smaller necrotic core, thicker fibrous cap and less apoptosis compared with those in &lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;AnxA8&lt;sup&gt;+/+&lt;/sup&gt;&lt;/i&gt;. BMT showed that hematopoietic AnxA8 deficiency had no effect on atherosclerotic progression. Oxidized low-density lipoprotein (ox-LDL) increased AnxA8 expression in murine aortic endothelial cells (MAECs). In vitro experiments revealed that &lt;i&gt;AnxA8&lt;/i&gt; deficiency in MAECs suppressed P/E-selectin and CD31 expression and secretion induced by ox-LDL with a concomitant reduction in platelet and leukocyte adhesion. Intravital microscopy confirmed the reduction in leukocyte and platelet adhesion in &lt;i&gt;ApoE&lt;sup&gt;−/−&lt;/sup&gt;AnxA8&lt;sup&gt;−/−&lt;/sup&gt;&lt;/i&gt; mice. Finally, endothelial-specific silencing of AnxA8 decreased atherosclerosis progression.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Our findings demonstrate that AnxA8 promotes the progression of atherosclerosis by modulating endothelial−leukocyte interactions. Interventions capable of reducing AnxA8 expre","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 1","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell landscape of the intrahepatic ecosystem in alcohol-related liver disease 酒精相关性肝病中肝内生态系统的单细胞景观
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-20 DOI: 10.1002/ctm2.70198
Xiaofang Zhao, Senyan Wang, Qi Liu, Wenjuan Wei, Xiaoyan Sun, Hao Song, Jing Xu, Shuijun Zhang, Hongyang Wang, Jing Fu

Alcohol-related liver disease (ALD) is a common chronic liver disease caused by long-term excessive alcohol consumption and responsible for more than half of all liver-related deaths worldwide. The molecular mechanisms associated with ALD were not fully understood. In this study, we performed single-cell RNA sequencing on liver tissues obtained from ALD patients and healthy liver donors. We identified an ALB+KRT7+ epithelial population that expressed both hepatocyte and biliary markers significantly expanded in ALD livers. The ALB+KRT7+ epithelial cells were demonstrated to have stem cell properties and malignant transformation potentials. Moreover, ALB+KRT7+ epithelium-derived ALD organoids promote the tumour growth by activating Wnt/β-catenin signalling of liver cancer cells. Most importantly, blocking the Wnt protein secretion or knockdown the Wnt receptor suppressed the tumour promoting effect of ALD organoids. Our study provides important insights that Wnt signalling can be targeted in patients with advanced alcohol-related cirrhosis to prevent malignant transformation. In addition, our results also uncovered the important alterations of nonparenchymal cells, especially macrophages and T/NK populations that responsible for active inflammation responses in alcohol-related hepatitis and immunosuppressive microenvironment in advanced cirrhosis livers, which likely facilitated the malignant progression of ALD.

Key points

  • This study provides single-cell landscape of human liver samples across different ALD stages.
  • The ALB+ KRT7+ epithelium were enriched in ALD patients, and the function of this epithelial population varied significantly across ALD stages.
  • ALB+KRT7+ epithelium from advanced alcohol-related cirrhosis had malignant transformation potential and tumour promotion activity.
  • The comprehensive changes of parenchymal and nonparenchymal cells in the ALD livers lay a hidden danger for the further malignant progression.
酒精相关性肝病(ALD)是一种由长期过量饮酒引起的常见慢性肝病,在全世界与肝脏相关的死亡中占一半以上。与ALD相关的分子机制尚不完全清楚。在这项研究中,我们对ALD患者和健康肝脏供者的肝组织进行了单细胞RNA测序。我们发现ALB+KRT7+上皮细胞群在ALD肝脏中表达肝细胞和胆道标志物显著扩增。结果表明,ALB+KRT7+上皮细胞具有干细胞特性和恶性转化潜能。此外,ALB+KRT7+上皮来源的ALD类器官通过激活肝癌细胞的Wnt/β-catenin信号传导促进肿瘤生长。最重要的是,阻断Wnt蛋白分泌或敲低Wnt受体可抑制ALD类器官的促肿瘤作用。我们的研究提供了重要的见解,即Wnt信号可以靶向晚期酒精相关性肝硬化患者以预防恶性转化。此外,我们的研究结果还揭示了非实质细胞,特别是巨噬细胞和T/NK细胞群的重要改变,这些细胞在酒精相关性肝炎和晚期肝硬化的免疫抑制微环境中负责活跃的炎症反应,这可能促进了ALD的恶性进展。本研究提供了不同ALD阶段人类肝脏样本的单细胞图谱。ALB+ KRT7+上皮在ALD患者中富集,并且该上皮群的功能在ALD的不同阶段有显著差异。晚期酒精相关性肝硬化的ALB+KRT7+上皮具有恶性转化潜能和肿瘤促进活性。ALD肝实质细胞和非实质细胞的全面改变为进一步恶性进展埋下了隐患。
{"title":"Single-cell landscape of the intrahepatic ecosystem in alcohol-related liver disease","authors":"Xiaofang Zhao,&nbsp;Senyan Wang,&nbsp;Qi Liu,&nbsp;Wenjuan Wei,&nbsp;Xiaoyan Sun,&nbsp;Hao Song,&nbsp;Jing Xu,&nbsp;Shuijun Zhang,&nbsp;Hongyang Wang,&nbsp;Jing Fu","doi":"10.1002/ctm2.70198","DOIUrl":"10.1002/ctm2.70198","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Alcohol-related liver disease (ALD) is a common chronic liver disease caused by long-term excessive alcohol consumption and responsible for more than half of all liver-related deaths worldwide. The molecular mechanisms associated with ALD were not fully understood. In this study, we performed single-cell RNA sequencing on liver tissues obtained from ALD patients and healthy liver donors. We identified an ALB<sup>+</sup>KRT7<sup>+</sup> epithelial population that expressed both hepatocyte and biliary markers significantly expanded in ALD livers. The ALB<sup>+</sup>KRT7<sup>+</sup> epithelial cells were demonstrated to have stem cell properties and malignant transformation potentials. Moreover, ALB<sup>+</sup>KRT7<sup>+</sup> epithelium-derived ALD organoids promote the tumour growth by activating Wnt/β-catenin signalling of liver cancer cells. Most importantly, blocking the Wnt protein secretion or knockdown the Wnt receptor suppressed the tumour promoting effect of ALD organoids. Our study provides important insights that Wnt signalling can be targeted in patients with advanced alcohol-related cirrhosis to prevent malignant transformation. In addition, our results also uncovered the important alterations of nonparenchymal cells, especially macrophages and T/NK populations that responsible for active inflammation responses in alcohol-related hepatitis and immunosuppressive microenvironment in advanced cirrhosis livers, which likely facilitated the malignant progression of ALD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Key points</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>This study provides single-cell landscape of human liver samples across different ALD stages.</li>\u0000 \u0000 <li>The ALB<sup>+</sup> KRT7<sup>+</sup> epithelium were enriched in ALD patients, and the function of this epithelial population varied significantly across ALD stages.</li>\u0000 \u0000 <li>ALB<sup>+</sup>KRT7<sup>+</sup> epithelium from advanced alcohol-related cirrhosis had malignant transformation potential and tumour promotion activity.</li>\u0000 \u0000 <li>The comprehensive changes of parenchymal and nonparenchymal cells in the ALD livers lay a hidden danger for the further malignant progression.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 1","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11746962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives 解读人类疾病中的假尿嘧啶核碱基修饰:从分子机制到临床观点。
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-20 DOI: 10.1002/ctm2.70190
Shiheng Jia, Xue Yu, Na Deng, Chen Zheng, Mingguang Ju, Fanglin Wang, Yixiao Zhang, Ziming Gao, Yanshu Li, Heng Zhou, Kai Li

RNA pseudouridylation, a dynamic and reversible post-transcriptional modification found in diverse RNA species, is crucial for various biological processes, including tRNA homeostasis, tRNA transport, translation initiation regulation, pre-mRNA splicing, enhancement of mRNA translation, and translational fidelity. Disruption of pseudouridylation impairs cellular homeostasis, contributing to pathological alterations. Recent studies have highlighted its regulatory role in human diseases, particularly in tumourigenesis. Cellular stresses trigger RNA pseudouridylation in organisms, suggesting that pseudouridylation-mediated epigenetic reprogramming is essential for maintaining cellular viability and responding to stress. This review examines the regulatory mechanisms and pathological implications of pseudouridylation in human diseases, with a focus on its involvement in tumourigenesis. Additionally, it explores the therapeutic potential of targeting pseudouridylation, presenting novel strategies for disease treatment.

Highlights

  • Methods to detect pseudouridine were introduced from classic mass spectrometry-based methods to newer approaches such as nanopore-based technologies and BID sequencing, each with its advantages and limitations.
  • RNA pseudouridylation is crucial for various biological processes, including tRNA homeostasis, tRNA transport, translation initiation regulation, pre-mRNA splicing, enhancement of mRNA translation, and translational fidelity.
  • Increased pseudouridylation is frequently associated with tumour initiation, progression, and poor prognosis, whereas its reduction is predominantly implicated in non-tumour diseases.
  • A comprehensive understanding of the inducing factors for RNA pseudouridylation will be essential for elucidating its role in diseases. Such insights can provide robust evidence for how pseudouridylation influences disease progression and offer new avenues for therapeutic strategies targeting pseudouridylation dysregulation.
  • The therapeutic potential of RNA pseudouridylation in diseases is enormous, including inhibitors targeting pseudouridine synthases, the application of RNA pseudouridylation in RNA therapeutics, and its role as a biological marker.
RNA假尿嘧啶化是一种动态可逆的转录后修饰,存在于多种RNA物种中,对多种生物过程至关重要,包括tRNA稳态、tRNA转运、翻译起始调控、mRNA前剪接、mRNA翻译增强和翻译保真度。假尿嘧啶化的破坏会损害细胞稳态,导致病理改变。最近的研究强调了它在人类疾病,特别是肿瘤发生中的调节作用。细胞应激触发RNA假尿嘧啶化,提示假尿嘧啶化介导的表观遗传重编程对于维持细胞活力和应对应激至关重要。本文综述了假尿嘧啶化在人类疾病中的调控机制和病理意义,重点讨论了其在肿瘤发生中的作用。此外,它还探讨了靶向假尿嘧啶化的治疗潜力,为疾病治疗提供了新的策略。重点介绍了假尿嘧啶的检测方法,从经典的基于质谱的方法到基于纳米孔的技术和BID测序等新方法,每种方法都有其优点和局限性。RNA假尿嘧啶化对多种生物过程至关重要,包括tRNA稳态、tRNA转运、翻译起始调控、mRNA前剪接、mRNA翻译增强和翻译保真度。假尿嘧啶化增加通常与肿瘤的发生、进展和预后不良有关,而其减少主要与非肿瘤疾病有关。全面了解RNA假尿嘧啶化的诱导因子对于阐明其在疾病中的作用至关重要。这些见解可以为假尿嘧啶化如何影响疾病进展提供有力的证据,并为针对假尿嘧啶化失调的治疗策略提供新的途径。RNA假尿嘧啶化在疾病中的治疗潜力是巨大的,包括靶向假尿嘧啶合成酶的抑制剂,RNA假尿嘧啶化在RNA治疗中的应用,以及它作为生物标志物的作用。
{"title":"Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives","authors":"Shiheng Jia,&nbsp;Xue Yu,&nbsp;Na Deng,&nbsp;Chen Zheng,&nbsp;Mingguang Ju,&nbsp;Fanglin Wang,&nbsp;Yixiao Zhang,&nbsp;Ziming Gao,&nbsp;Yanshu Li,&nbsp;Heng Zhou,&nbsp;Kai Li","doi":"10.1002/ctm2.70190","DOIUrl":"10.1002/ctm2.70190","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>RNA pseudouridylation, a dynamic and reversible post-transcriptional modification found in diverse RNA species, is crucial for various biological processes, including tRNA homeostasis, tRNA transport, translation initiation regulation, pre-mRNA splicing, enhancement of mRNA translation, and translational fidelity. Disruption of pseudouridylation impairs cellular homeostasis, contributing to pathological alterations. Recent studies have highlighted its regulatory role in human diseases, particularly in tumourigenesis. Cellular stresses trigger RNA pseudouridylation in organisms, suggesting that pseudouridylation-mediated epigenetic reprogramming is essential for maintaining cellular viability and responding to stress. This review examines the regulatory mechanisms and pathological implications of pseudouridylation in human diseases, with a focus on its involvement in tumourigenesis. Additionally, it explores the therapeutic potential of targeting pseudouridylation, presenting novel strategies for disease treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Highlights</h3>\u0000 \u0000 <div>\u0000 <ul>\u0000 \u0000 <li>Methods to detect pseudouridine were introduced from classic mass spectrometry-based methods to newer approaches such as nanopore-based technologies and BID sequencing, each with its advantages and limitations.</li>\u0000 \u0000 <li>RNA pseudouridylation is crucial for various biological processes, including tRNA homeostasis, tRNA transport, translation initiation regulation, pre-mRNA splicing, enhancement of mRNA translation, and translational fidelity.</li>\u0000 \u0000 <li>Increased pseudouridylation is frequently associated with tumour initiation, progression, and poor prognosis, whereas its reduction is predominantly implicated in non-tumour diseases.</li>\u0000 \u0000 <li>A comprehensive understanding of the inducing factors for RNA pseudouridylation will be essential for elucidating its role in diseases. Such insights can provide robust evidence for how pseudouridylation influences disease progression and offer new avenues for therapeutic strategies targeting pseudouridylation dysregulation.</li>\u0000 \u0000 <li>The therapeutic potential of RNA pseudouridylation in diseases is enormous, including inhibitors targeting pseudouridine synthases, the application of RNA pseudouridylation in RNA therapeutics, and its role as a biological marker.</li>\u0000 </ul>\u0000 </div>\u0000 </section>\u0000 </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 1","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11746961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathogenic variants of TUBB8 cause oocyte spindle defects by disrupting with EB1/CAKP5 interactions and potential treatment targeting microtubule acetylation through HDAC6 inhibition TUBB8致病性变异通过破坏EB1/CAKP5相互作用和通过抑制HDAC6靶向微管乙酰化的潜在治疗,导致卵母细胞纺锤体缺陷。
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-20 DOI: 10.1002/ctm2.70193
Hui Luo, Jianhua Chen, Cao Li, Tian Wu, Siyue Yin, Guangping Yang, Yipin Wang, Zhihan Guo, Saifei Hu, Yanni He, Yingnan Wang, Yao Chen, Youqiang Su, Congxiu Miao, Yun Qian, Ruizhi Feng

Background

Numerous pathogenic variants causing human oocyte maturation arrest have been reported on the primate-specific TUBB8 gene. The main etiology is the dramatic reduction of tubulin α/β dimer, but still large numbers of variants remain unexplained.

Methods

Using microinjection mRNA and genome engineering to reintroduce the conserved pathogenic missense variants into oocytes or in generating TUBB8 variant knock-in mouse models, we investigated that the human deleterious variants alter microtubule nucleation and spindle assembly during meiosis. Live-cell imaging and immunofluorescence were utilised to track the dynamic expression of microtubule plus end-tracking proteins in vivo and analysed microtubule nucleation or spindle assembly in vitro, respectively. Immunoprecipitation-mass spectrometry and ultramicro-quantitative proteomics were performed to identify the differential abundance proteins and affected interactome of TUBB8 protein.

Results

First, we observed a significant depletion of the EB1 signal upon microinjection of mutated TUBB8 mRNA (including R262Q, M300I, and D417N missense variants), indicating disruption of microtubule nucleation caused by these introduced TUBB8 missense variants. Mechanically, we demonstrated that the in vivo TUBB8-D417N missense variant diminished the affinity of EB1 and microtubules. It also harmed the interaction between microtubules and CKAP5/TACC3, which are crucial for initiating microtubule nucleation. Attenuated Ran-GTP pathway was also found in TUBB8-D417N oocytes, leading to disrupted spindle assembly. Stable microtubule was largely abolished on the spindle of TUBB8-D417N oocytes, reflected by reduced tubulin acetylation and accumulated HDAC6. More importantly, selective inhibition of HDAC6 by culturing TUBB8-D417N oocytes with Tubacin or Tubastatin A showed morphologically normal spindle and drastically recovered polar-body extrusion rate. These rescue results shed light on the strategy to treat meiotic defects in a certain group of TUBB8 mutated patients.

Conclusion

Our study provides a comprehensive mechanism elucidating how TUBB8 missense variants cause oocyte maturation arrest and offers new therapeutic avenues for treating female infertility in the clinic.

背景:在灵长类动物特异性的TUBB8基因上已经报道了许多导致人类卵母细胞成熟停滞的致病变异。主要病因是微管蛋白α/β二聚体的显著减少,但仍有大量的变异尚未解释。方法:利用微注射mRNA和基因组工程技术将保守的致病错义变异体重新引入卵母细胞或建立TUBB8变异体敲入小鼠模型,研究人类有害变异体在减数分裂过程中对微管成核和纺锤体组装的影响。利用活细胞成像和免疫荧光技术在体内跟踪微管和末端跟踪蛋白的动态表达,并分别分析微管成核或纺锤体组装。采用免疫沉淀-质谱法和超微定量蛋白质组学方法鉴定差异丰度蛋白和受影响的TUBB8蛋白相互作用组。结果:首先,我们观察到微注射突变的TUBB8 mRNA(包括R262Q、M300I和D417N错义变体)后EB1信号明显缺失,表明这些引入的TUBB8错义变体导致微管成核破坏。机械地,我们证明了体内TUBB8-D417N错义变体降低了EB1和微管的亲和力。它还破坏了微管与CKAP5/TACC3之间的相互作用,而这是启动微管成核的关键。在TUBB8-D417N卵母细胞中也发现了减弱的Ran-GTP通路,导致纺锤体组装中断。TUBB8-D417N卵母细胞纺锤体上的稳定微管大量消失,表现为微管蛋白乙酰化减少和HDAC6积累。更重要的是,用Tubacin或Tubastatin A培养TUBB8-D417N卵母细胞,选择性抑制HDAC6后,纺锤体形态正常,极体挤压率大幅恢复。这些挽救结果揭示了治疗某些TUBB8突变患者减数分裂缺陷的策略。结论:本研究提供了TUBB8错义变异导致卵母细胞成熟阻滞的综合机制,为临床治疗女性不孕症提供了新的治疗途径。
{"title":"Pathogenic variants of TUBB8 cause oocyte spindle defects by disrupting with EB1/CAKP5 interactions and potential treatment targeting microtubule acetylation through HDAC6 inhibition","authors":"Hui Luo,&nbsp;Jianhua Chen,&nbsp;Cao Li,&nbsp;Tian Wu,&nbsp;Siyue Yin,&nbsp;Guangping Yang,&nbsp;Yipin Wang,&nbsp;Zhihan Guo,&nbsp;Saifei Hu,&nbsp;Yanni He,&nbsp;Yingnan Wang,&nbsp;Yao Chen,&nbsp;Youqiang Su,&nbsp;Congxiu Miao,&nbsp;Yun Qian,&nbsp;Ruizhi Feng","doi":"10.1002/ctm2.70193","DOIUrl":"10.1002/ctm2.70193","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Numerous pathogenic variants causing human oocyte maturation arrest have been reported on the primate-specific TUBB8 gene. The main etiology is the dramatic reduction of tubulin α/β dimer, but still large numbers of variants remain unexplained.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Using microinjection mRNA and genome engineering to reintroduce the conserved pathogenic missense variants into oocytes or in generating TUBB8 variant knock-in mouse models, we investigated that the human deleterious variants alter microtubule nucleation and spindle assembly during meiosis. Live-cell imaging and immunofluorescence were utilised to track the dynamic expression of microtubule plus end-tracking proteins in vivo and analysed microtubule nucleation or spindle assembly in vitro, respectively. Immunoprecipitation-mass spectrometry and ultramicro-quantitative proteomics were performed to identify the differential abundance proteins and affected interactome of TUBB8 protein.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>First, we observed a significant depletion of the EB1 signal upon microinjection of mutated TUBB8 mRNA (including R262Q, M300I, and D417N missense variants), indicating disruption of microtubule nucleation caused by these introduced TUBB8 missense variants. Mechanically, we demonstrated that the in vivo TUBB8-D417N missense variant diminished the affinity of EB1 and microtubules. It also harmed the interaction between microtubules and CKAP5/TACC3, which are crucial for initiating microtubule nucleation. Attenuated Ran-GTP pathway was also found in TUBB8-D417N oocytes, leading to disrupted spindle assembly. Stable microtubule was largely abolished on the spindle of TUBB8-D417N oocytes, reflected by reduced tubulin acetylation and accumulated HDAC6. More importantly, selective inhibition of HDAC6 by culturing TUBB8-D417N oocytes with Tubacin or Tubastatin A showed morphologically normal spindle and drastically recovered polar-body extrusion rate. These rescue results shed light on the strategy to treat meiotic defects in a certain group of TUBB8 mutated patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our study provides a comprehensive mechanism elucidating how TUBB8 missense variants cause oocyte maturation arrest and offers new therapeutic avenues for treating female infertility in the clinic.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 1","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11746963/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How the brain produces generalized fear 大脑是如何产生普遍性恐惧的。
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-17 DOI: 10.1002/ctm2.70124
Hui-Quan Li, Nicholas C. Spitzer
<p>Fear alerts us to threats and is essential to survival. Acquired fear that is associated with a specific stimulus is defined as conditioned fear. However, fear can frequently generalize to other stimuli and contexts, and this generalized fear to harmless situations is a key component of anxiety that can result from acute stress. Generalized fear that is inappropriate to the stimuli that provoke it can be disadvantageous, destructive and even dangerous. Understanding how fear generalization occurs and how it can be controlled may suggest directions for the development of novel therapies to treat or even cure fear disorders.</p><p>In our study, we investigated the effect of footshock, a form of acute stress, which causes freezing behaviour that is a measure of fear in rodents. We found that a mild footshock given to mice produced only conditioned fear, but a strong footshock produced both conditioned and generalized fear (Figure 1A). We also found that footshock produced conditioned fear immediately, but generalized fear was present only after a three-day delay. The production of generalized fear was tightly associated with a change in co-transmitter identity from excitatory neurotransmitter glutamate to inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in serotonergic neurons in the dorsal raphe (Figure 1B).<span><sup>1</sup></span> No change in birth or death of neurons was detected that could account for changes in neurotransmitter expression.</p><p>Using a stable genetic marker to track the neurons, the change in co-transmitter was seen to occur in single cells—thus revealing a co-transmitter switch. There was no gender difference identified for the production of either conditioned or generalized fear or for the induction of the transmitter switch. The switching neurons made connections to neurons in the central amygdala and lateral hypothalamus, which are regions of the brain that mediate fear responses.</p><p>To learn whether the findings in rodents were translatable to humans, we then examined the postmortem brains of individuals with and without posttraumatic stress disorder (PTSD) provided by the National Institutes of Health NeuroBioBank. We observed a change in co-transmitter expression in the brains of individuals with PTSD, but not in the brains of age-, gender-, and postmortem interval-matched control subjects. The changes seen in PTSD individuals are consistent with those observed in footshocked mice that exhibited generalized fear.</p><p>When we suppressed the synthesis of GABA in footshock mice using adeno-associated virus (AAV)-based gene transfer tools to interfere with the expression of GABA synthase, we prevented the appearance of generalized fear in response to footshock. This result suggested that the transmitter switch is necessary for the acquisition of generalized fear. Re-establishing the function of glutamatergic transmission, by restoring the lost glutamate transporters using AAV tools, was not as effective
{"title":"How the brain produces generalized fear","authors":"Hui-Quan Li,&nbsp;Nicholas C. Spitzer","doi":"10.1002/ctm2.70124","DOIUrl":"10.1002/ctm2.70124","url":null,"abstract":"&lt;p&gt;Fear alerts us to threats and is essential to survival. Acquired fear that is associated with a specific stimulus is defined as conditioned fear. However, fear can frequently generalize to other stimuli and contexts, and this generalized fear to harmless situations is a key component of anxiety that can result from acute stress. Generalized fear that is inappropriate to the stimuli that provoke it can be disadvantageous, destructive and even dangerous. Understanding how fear generalization occurs and how it can be controlled may suggest directions for the development of novel therapies to treat or even cure fear disorders.&lt;/p&gt;&lt;p&gt;In our study, we investigated the effect of footshock, a form of acute stress, which causes freezing behaviour that is a measure of fear in rodents. We found that a mild footshock given to mice produced only conditioned fear, but a strong footshock produced both conditioned and generalized fear (Figure 1A). We also found that footshock produced conditioned fear immediately, but generalized fear was present only after a three-day delay. The production of generalized fear was tightly associated with a change in co-transmitter identity from excitatory neurotransmitter glutamate to inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in serotonergic neurons in the dorsal raphe (Figure 1B).&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; No change in birth or death of neurons was detected that could account for changes in neurotransmitter expression.&lt;/p&gt;&lt;p&gt;Using a stable genetic marker to track the neurons, the change in co-transmitter was seen to occur in single cells—thus revealing a co-transmitter switch. There was no gender difference identified for the production of either conditioned or generalized fear or for the induction of the transmitter switch. The switching neurons made connections to neurons in the central amygdala and lateral hypothalamus, which are regions of the brain that mediate fear responses.&lt;/p&gt;&lt;p&gt;To learn whether the findings in rodents were translatable to humans, we then examined the postmortem brains of individuals with and without posttraumatic stress disorder (PTSD) provided by the National Institutes of Health NeuroBioBank. We observed a change in co-transmitter expression in the brains of individuals with PTSD, but not in the brains of age-, gender-, and postmortem interval-matched control subjects. The changes seen in PTSD individuals are consistent with those observed in footshocked mice that exhibited generalized fear.&lt;/p&gt;&lt;p&gt;When we suppressed the synthesis of GABA in footshock mice using adeno-associated virus (AAV)-based gene transfer tools to interfere with the expression of GABA synthase, we prevented the appearance of generalized fear in response to footshock. This result suggested that the transmitter switch is necessary for the acquisition of generalized fear. Re-establishing the function of glutamatergic transmission, by restoring the lost glutamate transporters using AAV tools, was not as effective ","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 1","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11756554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced mutant receptor activator of nuclear factor kappa-Β ligand development with low affinity for osteoprotegerin 核因子kappa的高级突变受体激活因子-Β与骨保护素低亲和力的配体发育。
IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-17 DOI: 10.1002/ctm2.70195
Yuria Jang, Yongjin Cho, Youngjong Ko, Yeonhee Moon, Chang-Moon Lee, Wonbong Lim
<p>Dear Editor,</p><p>As a new receptor for receptor activator of nuclear factor kappa-Β ligand (RANKL), Leucine-rich repeat-containing G-protein coupled receptor 4 (LGR4) was recently introduced. Unlike RANKL–RANK signalling, RANKL-LGR4 inhibits the NFATc1 translocation, thereby inhibiting osteoclastic activity.<span><sup>1-3</sup></span> Novel mutant RANKL has been introduced in site-directed mutations at critical RANKL-RANK binding sites; it avoids RANK and binds to the LGR4, thereby inhibiting osteoclastogenesis.<span><sup>4-6</sup></span> However, a structure similar to that of RANKL has a weakness in the way that it can be scavenged by osteoprotegerin (OPG).<span><sup>7</sup></span> As OPG is an effective substance that removes RANKL, mutant RANKL can also be scavenged.<span><sup>8</sup></span> Therefore, an advanced RANKL mutation was performed for the LGR4 signalling trigger to inhibit osteoclast activity without affinity for OPG, and its applicability as a treatment for osteoporosis was investigated.</p><p>The previous mutant RANKL (001) containing transformants at K180R, D189I, R190K, H223F and H224Y and advanced mutant RANKL containing transformants at Q236D (011) or F269L (012), F269Y (013) and F269H (014) in the 011 and were generated for low affinity with OPG in wild type RANKL (WT) (Figure 1A and Figure S1).<span><sup>9, 10</sup></span> To determine the candidate with the lowest binding affinity to RANK and OPG (Figures S2 and S3), microscale thermophoresis (MST) was performed between RANK or OPG and mutant RANKL candidates in comparison to wild-type RANKL (WT) (Figure 1B,C). The binding affinity of 011 and 013 did not show with OPG. The binding affinity between RANK and 011/013 was about 17.1 µM and that between LGR4 and 013 showed the highest (about 8.59 µM and Figure S4). These results indicated 013 to be the potential candidates. To determine which mutant RANKL has the most inhibitory effect on osteoclast differentiation and activities, we stained tartrate-resistant acid phosphatase (TRAP) and analyzed resorbing pits on mutant RANKL candidates- or OPG-, as a positive control, and treated bone marrow-derived macrophage cells (BMMs) in the presence of WT. As a result, 013 showed the strongest inhibitory effect on trap-positive BMMs (Figure 1D,E) and caused a considerable dose-dependent decrease in TRAP-positive BMMs (Figure 1F,G). Furthermore, 013 decreased the resorption pit area in WT-treated BMMs (Figure 1H,I). Therefore, 013 plays an inhibitory role against osteoclast and could be a potential advanced mutant RANKL.</p><p>To investigate the effects of advanced mutant RANKL on the RANK or LGR4 signalling cascade, TRAP staining was performed on BMMs treated with only 013. Compared with WT, 013 did not result in TRAP-positive BMMs, even after treatment with 400 ng/mL (Figure 2A,B). A marked decrease in TRAP, NFATc1 and OSCAR (markers of osteoclast differentiation and activity) mRNA expressions was noted in 013+WT compared to WT (
{"title":"Advanced mutant receptor activator of nuclear factor kappa-Β ligand development with low affinity for osteoprotegerin","authors":"Yuria Jang,&nbsp;Yongjin Cho,&nbsp;Youngjong Ko,&nbsp;Yeonhee Moon,&nbsp;Chang-Moon Lee,&nbsp;Wonbong Lim","doi":"10.1002/ctm2.70195","DOIUrl":"10.1002/ctm2.70195","url":null,"abstract":"&lt;p&gt;Dear Editor,&lt;/p&gt;&lt;p&gt;As a new receptor for receptor activator of nuclear factor kappa-Β ligand (RANKL), Leucine-rich repeat-containing G-protein coupled receptor 4 (LGR4) was recently introduced. Unlike RANKL–RANK signalling, RANKL-LGR4 inhibits the NFATc1 translocation, thereby inhibiting osteoclastic activity.&lt;span&gt;&lt;sup&gt;1-3&lt;/sup&gt;&lt;/span&gt; Novel mutant RANKL has been introduced in site-directed mutations at critical RANKL-RANK binding sites; it avoids RANK and binds to the LGR4, thereby inhibiting osteoclastogenesis.&lt;span&gt;&lt;sup&gt;4-6&lt;/sup&gt;&lt;/span&gt; However, a structure similar to that of RANKL has a weakness in the way that it can be scavenged by osteoprotegerin (OPG).&lt;span&gt;&lt;sup&gt;7&lt;/sup&gt;&lt;/span&gt; As OPG is an effective substance that removes RANKL, mutant RANKL can also be scavenged.&lt;span&gt;&lt;sup&gt;8&lt;/sup&gt;&lt;/span&gt; Therefore, an advanced RANKL mutation was performed for the LGR4 signalling trigger to inhibit osteoclast activity without affinity for OPG, and its applicability as a treatment for osteoporosis was investigated.&lt;/p&gt;&lt;p&gt;The previous mutant RANKL (001) containing transformants at K180R, D189I, R190K, H223F and H224Y and advanced mutant RANKL containing transformants at Q236D (011) or F269L (012), F269Y (013) and F269H (014) in the 011 and were generated for low affinity with OPG in wild type RANKL (WT) (Figure 1A and Figure S1).&lt;span&gt;&lt;sup&gt;9, 10&lt;/sup&gt;&lt;/span&gt; To determine the candidate with the lowest binding affinity to RANK and OPG (Figures S2 and S3), microscale thermophoresis (MST) was performed between RANK or OPG and mutant RANKL candidates in comparison to wild-type RANKL (WT) (Figure 1B,C). The binding affinity of 011 and 013 did not show with OPG. The binding affinity between RANK and 011/013 was about 17.1 µM and that between LGR4 and 013 showed the highest (about 8.59 µM and Figure S4). These results indicated 013 to be the potential candidates. To determine which mutant RANKL has the most inhibitory effect on osteoclast differentiation and activities, we stained tartrate-resistant acid phosphatase (TRAP) and analyzed resorbing pits on mutant RANKL candidates- or OPG-, as a positive control, and treated bone marrow-derived macrophage cells (BMMs) in the presence of WT. As a result, 013 showed the strongest inhibitory effect on trap-positive BMMs (Figure 1D,E) and caused a considerable dose-dependent decrease in TRAP-positive BMMs (Figure 1F,G). Furthermore, 013 decreased the resorption pit area in WT-treated BMMs (Figure 1H,I). Therefore, 013 plays an inhibitory role against osteoclast and could be a potential advanced mutant RANKL.&lt;/p&gt;&lt;p&gt;To investigate the effects of advanced mutant RANKL on the RANK or LGR4 signalling cascade, TRAP staining was performed on BMMs treated with only 013. Compared with WT, 013 did not result in TRAP-positive BMMs, even after treatment with 400 ng/mL (Figure 2A,B). A marked decrease in TRAP, NFATc1 and OSCAR (markers of osteoclast differentiation and activity) mRNA expressions was noted in 013+WT compared to WT (","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 1","pages":""},"PeriodicalIF":7.9,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical and Translational Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1